These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26173716)

  • 1. Impact of alprazolam in allostatic load and neurocognition of patients with anxiety disorders and chronic stress (GEMA): observational study protocol.
    Soria CA; Remedi C; Núñez DA; D'Alessio L; Roldán EJ
    BMJ Open; 2015 Jul; 5(7):e007231. PubMed ID: 26173716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
    Kiejna A; Małyszczak K; Rzewuska M; Sobucka K; Florkowski A; Rajewski A; Rajewska J; Wojtanowska M; Dabkowski M; Brzeziński R; Rybakowski J; Sep-Kowalikowa B; Gałuszko P; Nowicki Z
    Psychiatr Pol; 1996; 30(6):973-92. PubMed ID: 9132771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Measures of Allostatic Load in Children and Adolescents with Food Allergy, Depression, or Anxiety.
    Ersig AL; Brown RL; Malecki K
    J Pediatr Nurs; 2021; 61():346-354. PubMed ID: 34555747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etifoxine versus alprazolam for the treatment of adjustment disorder with anxiety: a randomized controlled trial.
    Stein DJ
    Adv Ther; 2015 Jan; 32(1):57-68. PubMed ID: 25620535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High doses alprazolam induced amenorrhoea and galactorrhoea.
    Petrić D; Peitl MV; Peitl V
    Psychiatr Danub; 2011 Mar; 23(1):123-4. PubMed ID: 21448116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of individual differences in alprazolam self-medication.
    Oswald LM; Roache JD; Rhoades HM
    Exp Clin Psychopharmacol; 1999 Nov; 7(4):379-90. PubMed ID: 10609973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
    Frattola L; Garreau M; Piolti R; Bassi S; Albizzati MG; Borghi C; Morselli PL
    Br J Psychiatry; 1994 Jul; 165(1):94-100. PubMed ID: 7802852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients].
    Ropert R; Bernes J; Dachary JM
    Encephale; 1987; 13(2):89-95. PubMed ID: 2885173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allostatic Load and Personality: A 4-Year Longitudinal Study.
    Stephan Y; Sutin AR; Luchetti M; Terracciano A
    Psychosom Med; 2016 Apr; 78(3):302-10. PubMed ID: 26716813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental distress and personality in women undergoing GnRH agonist versus GnRH antagonist protocols for assisted reproductive technology.
    Stenbæk DS; Toftager M; Hjordt LV; Jensen PS; Holst KK; Bryndorf T; Holland T; Bogstad J; Pinborg A; Hornnes P; Frokjaer VG
    Hum Reprod; 2015 Jan; 30(1):103-10. PubMed ID: 25398970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
    Udelman HD; Udelman DL
    J Clin Psychiatry; 1990 Sep; 51 Suppl():46-50. PubMed ID: 2211568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allostasis and allostatic load: expanding the discourse on stress and cardiovascular disease.
    Logan JG; Barksdale DJ
    J Clin Nurs; 2008 Apr; 17(7B):201-8. PubMed ID: 18578796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC; Swinson RP; Kuch K; Lewis CP
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
    Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
    Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
    [No Abstract]   [Full Text] [Related]  

  • 15. Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition.
    Douzenis A; Michopoulos I; Economopoulos T; Lykouras L; Soldatos CR
    Eur J Cancer Care (Engl); 2007 May; 16(3):289-90. PubMed ID: 17508951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and electromyographic characteristics of tremor in patients with generalized anxiety disorder.
    Milanov I
    Electromyogr Clin Neurophysiol; 2007; 47(1):3-9. PubMed ID: 17375876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the usefulness and effectiveness of anxiolytic therapies in neoplastic diseases].
    Ziółko E; Knopik J; Bucior J; Foltyn W; Jastrzebska-Okoń K; Tomczyk A; Kempiński M
    Pol Merkur Lekarski; 2004 Jun; 16(96):561-4. PubMed ID: 15510897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.